April 01, 2013
Pfizer Inc. does not owe damages to employees whose company-managed retirement funds lost value when news emerged of possible dangerous side effects in drugs Bextra and Celebrex, a federal judge ruled Friday, dismissing a putative class action against the pharmaceutical giant.